IPO Update: Average Return Turns Negative For Newly Public Biopharma Firms
Number Of IPOs Tops 2020 Total With A Quarter Left In 2021
With 88 initial public offerings in the US through the end of the third quarter of 2021, the biopharma industry is two IPOs ahead of the full-year 2020 total, but with an average return of -4% momentum may slow.
